<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03169582</url>
  </required_header>
  <id_info>
    <org_study_id>HNParaplejicos</org_study_id>
    <nct_id>NCT03169582</nct_id>
  </id_info>
  <brief_title>Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction</brief_title>
  <official_title>Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction: Non- Inferiority, Randomized, Crossover, Open Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eduardo Vargas-Baquero</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Nacional de Parapléjicos de Toledo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of this study is to compare the use of Avanafil versus Sildenafil in spinal
      cord injury erectile dysfunction. The study has the characteristics of a non- inferiority,
      randomized, crossover, open clinical trial. The principal variable is the IIEF-EF (Erectile
      Function Domain questionnaire of the International Index of Erectile Function IIEF).

      This is an interventional study
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>non- inferiority, randomized, crossover, open clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IIEF-EF</measure>
    <time_frame>2 years</time_frame>
    <description>Erectile Function Domain questionnaire of the International Index of Erectile Function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SLQQ-Part II</measure>
    <time_frame>2 years</time_frame>
    <description>Sexual life quality Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GAQ</measure>
    <time_frame>2 years</time_frame>
    <description>Global Impression of efficacy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Avanafil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical evaluation of the two pharmacological interventions (Sildenafil vs Avanafil).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sildenafil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical evaluation of the two pharmacological interventions (Sildenafil vs Avanafil)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Avanafil</intervention_name>
    <description>Drug administration (Avanafil)</description>
    <arm_group_label>Avanafil</arm_group_label>
    <other_name>no other interventions</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil</intervention_name>
    <description>Drug administration (Sildenafil)</description>
    <arm_group_label>Sildenafil</arm_group_label>
    <other_name>no other interventions</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Spinal cord injury

          -  Erectile dysfunction

          -  No Medical Contraindication to use Avanafil and/or Sildenafil

          -  Able to provide informed consent

          -  Able to complete questionnaires

        Exclusion Criteria:

          -  Medical Contraindication to use Avanafil and/or Sildenafil

          -  No spinal cord injury

          -  Congenital spinal cord injury

          -  Not able to provide informed consent

          -  Not able to complete questionnaires
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eduardo Vargas-Baquero, MD</last_name>
    <phone>+34925247700</phone>
    <phone_ext>47748</phone_ext>
    <email>edua33@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Nacional de Paraplejicos</name>
      <address>
        <city>Toledo</city>
        <zip>45071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Vargas-Baquero, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2017</study_first_submitted>
  <study_first_submitted_qc>May 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2017</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Nacional de Parapléjicos de Toledo</investigator_affiliation>
    <investigator_full_name>Eduardo Vargas-Baquero</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

